Ever since Hans Popper, MD, regarded as the Father of Hepatology, joined the Icahn School of Medicine at Mount Sinai faculty in 1957, Mount Sinai has been at the forefront of groundbreaking advances in the detection and treatment of liver disease. Our physicians and researchers were the first to uncover the cells responsible for liver fibrosis, which can lead to cirrhosis. They were also leaders of clinical trials that led to the first FDA-approved treatment for patients with hepatitis C and HIV and a clinical trial that generated the first effective oral therapy for liver cancer. Our liver disease specialists employ the latest advances to provide expert diagnosis and personalized treatment plans that will help arrest or reverse their disease.
The Division of Liver Diseases at The Mount Sinai Hospital has been pioneering groundbreaking advances in the detection and treatment of liver diseases for more than half a century. Learn more
One of the largest adult and pediatric abdominal transplant centers in the world, the Recanati/Miller Transplantation Institute provides skilled care for patients with end-stage liver diseases. Learn more